In 96 patients suffering from multiple sclerosis (MS) 277 plasma exchanges (PE) including 176 lymphocytaphereses were performed. Improvement was mainly seen in patients with a short course of disease and at acute exacerbations. Patients with chronic progressive and relapsing intermittent courses responded only poorly. One or two PE were sufficient to induce improvement which was only marginally altered by subsequent PE.
Our data confirm that only selected patients will benefit from PE-treatment especially those with acute exacerbations.
AbramskyO., LisakR.P., SilberbergD.H., PleasureD.E.: Antibodies to oligodendroglia in patients with multiple sclerosis.N. Eng. J. Med.297: 1207–1211. 1977.
2.
AngstwurmH., and FrickE.zur Corticosteroid-behandlung der Multiplen Sklerose, München Med. Wschr.106 (1964), 39, 1718.
3.
AvertanoB.C..: Circulating immune complexes in neurologic disease.Neurology31, 1402–1407, 1981.
HöckerP., StellamorV., SummerK., MannM.: Plasmaexchange and Lymphocytapheresis in Multiple Sclerosis: Advanced Apheresis Seminar, Boston, April 1982.
11.
KhatriB.O., Mc QuillenM.P., KoetheS.M., HusseyC., CookA.: Plasmapheresis in multiple sclerosis: Correlation of clinical improvement with increased suppressor cell activity in peripheral blood.Ann. Neurolog.8: 114, 1980.
12.
LisakR.P., ZweimannB., NormannM.Antimyelin antibodies in neurologic diseases.Arch. Neurol.32: 163–167, 1975.
SchaufC.L., StefoskiD.A., DavisF.A., Mc LeodB.C.: Concerning the application of plasmapheresis to multiple sclerosis.Plasma Therapy1, 33–42, 1979.
20.
UchidaA., MaidaE.M., LenzhoferR., MickscheM.: Natural Killer Cell Activity in Patients with multiple sclerosis: Interferon and Plasmapheresis.Immunobiol., Vol. 160, pp. 392–402(1982).
21.
WegmüllerE.die therapeutische Bedeutung der Plasmapherese bei Immunkrankheiten.Schweiz. med. Wschr.111, 443–449, 1981.
22.
WeinerH.L., DawsonD.M.: Plasmapheresis in multiple sclerosis Preliminary study.Neurology30, 1029–1033, 1980.
23.
WoyciechowskaS.L., BroskoW.J.: Immunofluorescence study on brain plaques from the patients of multiple sclerosis.Neurology27, 620–622, 1977.
24.
ValbonesiM.: Plasma Exchange in the Management of Selected Neurological Diseases.Plasma Therapy Vol. 2 No. 1, 14.
25.
Van der HoartS., WaksmannB.H.Plasma exchange: Aid to therapy of multiple sclerosis.Neurology30, 1111, 1980.
26.
FogT.A.: Scoring system for neurological impairment in multiple sclerosis.Acta Neurolog. Scand.41. Suppl. 13, 1965.
